Outcomes for ERT-treated patients were compared with untreated natural history (NH) controls with CLN2 disease enrolled in the DEM-CHILD international neuronal ceroid lipofuscinosis (NCL) database, a clinical registry that enrolls children with different forms of NCL, including CLN2 disease (5, 6). Here, TPP1 is linked to infantile neuronal ceroid lipofuscinosis.